Bill Ackman Says Valeant Pharmaceuticals Bet Is Mirror Image Of His Herbalife Short |
November 10, 2015 | November 2015 Bond Updates |
Pershing Square's Bill Ackman said Valeant's tumble from above $250 a share to below $80 a share reminded him of Herbalife's surge in late 2013, which caused the stock to roughly double to about $80 a share. |
View more at: http://www.forbes.com/sites/antoinegara/2015/11/09/bill-ackman-says-his-valeant-pharmaceuticals-bet-is-at-an-herbalife-moment/ |
Related News |
|